Skip to main content
FinSpry Logo
FinSpry
JANX logo
JANX
(NASDAQ)
Janux Therapeutics, Inc.
$14.91-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Janux Therapeutics (JANX) Stock Price & Financial Analysis

Janux Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.30 - $15.01
52-Week High$35.34
52-Week Low$12.12
Open$14.30
Volume1.19M
Average Volume (3M)934.02K
Market Cap898.63M
Shares Outstanding62.67M
Price to Sales (P/S)41.58
Price to Book (P/B)0.95
EV/EBITDA-7.02
Revenue (TTM)21.61M
Net Income (TTM)-114.48M
Free Cash Flow (TTM)-78.49M
EPS (TTM)$-1.84
Profit Margin-529.67%
Operating Margin-726.34%
Return on Equity (ROE)-12.16%
Debt to Equity0.02
50-Day MA$14.40
200-Day MA$18.00
52-Week Change-39.24%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Janux Therapeutics

What is the current stock price for JANX?

As of the latest trading session, JANX stock trades at $14.91. The 52-week range is $12.12–$35.34, with a day range of $14.30–$15.01.

What is the P/E ratio for JANX?

The P/E ratio (Price-to-Earnings) for JANX is shown in the Key Statistics section. This valuation metric helps compare Janux Therapeutics, Inc. to industry peers.

Does JANX pay dividends?

Janux Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for JANX?

Based on 14 analysts, the consensus for JANX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JANX?

Janux Therapeutics's market capitalization is $934.3M, classifying it as a small-cap company. Janux Therapeutics operates in the Healthcare sector within the Biotechnology industry.